Patent · US Expired

Monoclonal antibodies having binding specificity to human prostate tumor-associated antigens and methods for employing the same

US5153118A · kind A · utility

30Cited by

3References

12Claims

0Family size

Assignee

Eastern Virginia Medical Authority · US

Inventors

George L. Wright · Corrales, US
James J. Starling · Carmel, US

Key dates

Filing date	Oct 25, 1988
Grant date	Oct 6, 1992
Priority date	—
Expiry date	Oct 25, 2008

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/861
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Monoclonal antibodies having binding specificity to human prostate tumor-associated antigens but not to prostate-specific antigen (PSA) or prostatic acid phosphatase (PAP); and methods of diagnosis and treatment employing the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.